Evolus (EOLS) EBIT Margin (2019 - 2026)
Evolus' EBIT Margin came in at -10.81% for Q3 2026, up 5.86 percentage points from -16.67% a year earlier but down 5.41 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) EBIT Margin (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Evolus reported EBIT Margin of -4.79%, up 8.92 percentage points year-over-year; for FY2025, it was -10.99%, up 1.93 percentage points from FY2024.
- EBIT Margin has increased in each of the last six years, with a five-year change of +259.73 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -12.92% in FY2024 (+11.44 pp), -24.36% in FY2023 (+19.60 pp), -43.96% in FY2022 (+0.59 pp) and -44.55% in FY2021 (+226.17 pp).
- The five-year range for quarterly EBIT Margin is -57.44% (Q2 2022) to 4.67% (Q4 2025).
- Year-over-year, EBIT Margin has increased for five consecutive quarters, with an average year-over-year change of +5.64 percentage points over the last eight quarters.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2021 (a gain of 472.97 percentage points), and the weakest in Q1 2022 (a drop of 111.13 percentage points).
- Business Quant data shows EOLS's EBIT Margin at -5.40% (Q2 2026), -9.36% (Q1 2026) and 4.67% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Evolus | 455.33 Mn | 264.84 Mn | 50.69 Mn | -10.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -10.81% |
| Jun 30, 2026 | -5.40% |
| Mar 31, 2026 | -9.36% |
| Dec 31, 2025 | 4.67% |
| Sep 30, 2025 | -16.67% |
| Jun 30, 2025 | -14.71% |
| Mar 31, 2025 | -22.14% |
| Dec 31, 2024 | -2.93% |
| Sep 30, 2024 | -25.33% |
| Jun 30, 2024 | -11.51% |
| Mar 31, 2024 | -15.04% |
| Dec 31, 2023 | -14.16% |
| Sep 30, 2023 | -26.87% |
| Jun 30, 2023 | -30.64% |
| Mar 31, 2023 | -28.86% |
| Dec 31, 2022 | -24.37% |
| Sep 30, 2022 | -52.80% |
| Jun 30, 2022 | -57.44% |
| Mar 31, 2022 | -45.56% |
| Dec 31, 2021 | -52.02% |
API Access
Evolus EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();